Home > Healthcare > Biotechnology > Biopharma > Bioink Market

Bioink Market Share

Report ID: GMI9118
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Bioink Market Share

The competitive landscape of the market is characterized by the presence of established pharmaceutical and biotechnology companies that are involved in drug discovery and development vying for market share. Key players are engaging in strategic initiatives such as product launch, collaboration, investment, and partnerships to strengthen their product portfolio. Companies are actively adopting multi-pronged approaches to address the rising demand for bioink.

Bioink Market Companies

Prominent players operating in the bioink industry are as mentioned below:

Allevi, Inc. (3D Systems)
Axolotl Biosciences
BIO INX
CELLLINK (BICO)
CollPlant Biotechnologies Ltd
Foldink
Gelomics
INNOREGEN, Inc.
Merck KGaA
Rokit Healthcare
TheWell Bioscience Inc.
UPM Biomedicals
Viscient Biosciences
VoxCell BioInnovation Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The bioink industry was valued at USD 70.4 million in 2023 and is estimated to grow at a 12.5% CAGR from 2024 to 2032, driven by increasing applications in biomedical research and therapy, and a rising incidence of chronic diseases and organ failures.

The natural bioinks segment recorded USD 60.7 million in 2023 and is expected to dominate the market due to their biocompatibility, non-toxicity, and sustainability.

The North America bioink market recorded a substantial share of 43.6% in 2023 and is expected to maintain its dominance throughout the forecast period. This growth is attributed to the availability of technologically advanced bioink products, such as improved printing resolution, multi-material printing capabilities, and integrated bioprinting systems.

Key players in the bioink industry include Allevi, Inc. (3D Systems), Axolotl Biosciences, BIO INX, CELLLINK (BICO), CollPlant Biotechnologies Ltd, Foldink, Gelomics, INNOREGEN, Inc., and Merck KGaA.